← Back to Events
ONCOLOGY CONCLUDED
International Cancer &
CIOC brings together oncology and IO research with tracks on novel therapies, imaging, and policy, positioned at the intersection of basic research and patient care. It attracts Asian clinical and academic networks, valuable for regional trial planning and APAC-focused IO rollouts in hybrid format.[1][7]
Coverage & Analysis
No coverage articles yet. Check back closer to the event.
🌏 Latest Asia-Pacific News
All news → May 4 Telix Pharmaceuticals' TLX250-Px Shows Promise for Diagnosing Multiple Kidney Cancer Types Beyond Clear Cell RCC May 4 Arrowhead Pharmaceuticals Receives TGA Approval for REDEMPLO (Plozasiran) in Australia for Rare Metabolic Disorder May 4 Mifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling May 4 XtalPi-Enabled PEP08 PRMT5 Inhibitor Begins Phase I Cancer Trial Enrollment May 4 SPONTAN Phase II Data Shows 10-Minute Onset Time, Meets FDA Requirements for Erectile Dysfunction Treatment